Articles and Insights About Wearables for Clinical Trials

Changing Perspectives in Digital Measure Development

 Ieuan Clay, PhD

Ieuan Clay, VivoSense Director of Science, presented at the Mobilise-D Conference to discuss what can be measured, what should be measured, and what must be measured, along with some examples of putting it into practice. Watch the video or check out his slides for a quick snapshot of his presentation!

Read More

Wearable Sensors in Clinical Trials: Data System Integrity

 Dudley Tabakin

Digital health technologies, including wearable sensors, are being considered as solutions that will revolutionize clinical trials, deliver clinically meaningful endpoints, reduce study costs, and engage patients. However, for all this to take place, the data collected must be trustworthy; the systems in place should be robust; and the sensor deployment, data collection, compliance monitoring, data aggregation, data analysis, and delivery should be auditable and secure.

Read More

Scope 2024: Driving Innovation in Clinical Trials and Digital Health

 Rob Wilson

At the 15th Annual SCOPE Meeting in Orlando, “Driving Innovation in Clinical Trials and Digital Health,” representatives from across the clinical trial ecosystem shared case studies and described their commitment and approach to improving patient health through better clinical trials. 

Read More

Patient-Centric Digital Endpoints of Function for AD Research

 Jen Blankenship, PhD

At the ISCTM 20th Annual Scientific Meeting, Senior Research Scientist Jen Blankenship, PhD, presented our ongoing work to understand patient perspectives on how mild AD impacts their daily life and function and identify the meaningful aspects of health that are measurable with low-burden wearable actigraphy sensors. Download the poster and read the abstract below.

Read More

VivoSense Marks Rare Disease Day

 Dudley Tabakin

VivoSense recognizes Rare Disease Day by minding the importance of discovering new advancements in research and clinical trials to care for those with rare diseases. There are approximately 30 million Americans living with rare diseases today, and research into new therapies is imperative for these patients.

Read More

Why You Should Include Digital Endpoints in Clinical Trials

 Jen Blankenship, PhD

See how research teams can start using wearables to identify novel digital biomarkers to efficiently generate real-world patient evidence in clinical trials.

Read More

Webinar: Holistic Measures of Physical Functioning in Cancer

 VivoSense Team

Suvekshya Aryal, a VivoSense Research scientist, moderated a live discussion about the holistic measurement of physical function in cancer and opportunities for digital health technologies to provide value.

Read More

Measuring What Is Meaningful in Cancer Cachexia Clinical Trials

 VivoSense Team

VivoSense recently published an American Society of Clinical Oncology's JCO Clinical Cancer Informatics review article, Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior.

Read More

Capturing Real-World Physical Behavior in Cancer Survivors

 Shelby Bachman, PhD

VivoSense Research Scientist Shelby Bachman, PhD, presented the poster, Real-world physical behavior is associated with aerobic fitness, but not patient-reported outcomes, in cancer survivors, at the October 22, 2023, Banff 9th Annual PROMIS International Conference, a multi-disciplinary forum for learning about the use of patient-reported outcome measures in clinical care and research. Shelby’s poster presentation summarized VivoSense’s recent work examining the clinical utility of real-world digital measures in oncology. Here's a quick snapshot of the poster content.

Read More

Novel Digital Sleep Assessment Tools in Major Depressive Disorder

 VivoSense Team

VivoSense published a Karger review article, The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder.

Read More

Stay Connected

Popular